Fred Mermelstein

1.9k total citations
27 papers, 1.6k citations indexed

About

Fred Mermelstein is a scholar working on Molecular Biology, Surgery and Anesthesiology and Pain Medicine. According to data from OpenAlex, Fred Mermelstein has authored 27 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Surgery and 7 papers in Anesthesiology and Pain Medicine. Recurrent topics in Fred Mermelstein's work include Pain Management and Opioid Use (6 papers), Anesthesia and Pain Management (6 papers) and Genomics and Chromatin Dynamics (5 papers). Fred Mermelstein is often cited by papers focused on Pain Management and Opioid Use (6 papers), Anesthesia and Pain Management (6 papers) and Genomics and Chromatin Dynamics (5 papers). Fred Mermelstein collaborates with scholars based in United States, Netherlands and Israel. Fred Mermelstein's co-authors include Danny Reinberg, William S. Lane, Ilho Ha, Brian David Dynlacht, Ronny Drapkin, Robert P. Fisher, David O. Morgan, Ramin Shiekhattar, Daniel B. Carr and Douglas A. Hamilton and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Fred Mermelstein

27 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fred Mermelstein United States 18 1.1k 251 190 163 160 27 1.6k
Mark Worthington United States 16 792 0.7× 186 0.7× 65 0.3× 53 0.3× 75 0.5× 32 1.6k
Richard A. Lewis United Kingdom 20 461 0.4× 61 0.2× 162 0.9× 173 1.1× 130 0.8× 37 1.3k
Rong Zhao China 15 598 0.6× 132 0.5× 35 0.2× 97 0.6× 78 0.5× 45 1.2k
Ken Iseki Japan 18 536 0.5× 70 0.3× 128 0.7× 43 0.3× 122 0.8× 82 1.2k
J Otten Belgium 10 525 0.5× 113 0.5× 118 0.6× 42 0.3× 96 0.6× 21 937
Christopher T. Campbell United States 19 862 0.8× 58 0.2× 56 0.3× 53 0.3× 98 0.6× 37 1.3k
Lingyan Wang China 19 437 0.4× 106 0.4× 64 0.3× 120 0.7× 90 0.6× 109 1.1k
Hideo Fukui Japan 17 363 0.3× 61 0.2× 37 0.2× 45 0.3× 241 1.5× 47 1.0k
Guoshuai Cai United States 19 659 0.6× 148 0.6× 58 0.3× 64 0.4× 57 0.4× 61 1.2k
Wei Cui China 25 1.1k 1.0× 259 1.0× 72 0.4× 56 0.3× 80 0.5× 56 1.8k

Countries citing papers authored by Fred Mermelstein

Since Specialization
Citations

This map shows the geographic impact of Fred Mermelstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Mermelstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Mermelstein more than expected).

Fields of papers citing papers by Fred Mermelstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred Mermelstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Mermelstein. The network helps show where Fred Mermelstein may publish in the future.

Co-authorship network of co-authors of Fred Mermelstein

This figure shows the co-authorship network connecting the top 25 collaborators of Fred Mermelstein. A scholar is included among the top collaborators of Fred Mermelstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred Mermelstein. Fred Mermelstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mermelstein, Fred, et al.. (2019). Vaginal tamoxifen for treatment of vulvar and vaginal atrophy: Pharmacokinetics and local tolerance in a rabbit model over 28 days. International Journal of Pharmaceutics. 570. 118691–118691. 2 indexed citations
2.
Meyn, LA, et al.. (2019). Weekly vaginal administration of tamoxifen for three months in postmenopausal women with vulvar and vaginal atrophy: a possible new treatment approach?. Clinical and Experimental Obstetrics & Gynecology. 46(2). 285–288. 1 indexed citations
3.
4.
Meyn, Leslie A., et al.. (2009). Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis. Menopause The Journal of The North American Menopause Society. 16(5). 978–983. 22 indexed citations
5.
Christensen, Kyle S., Fred Mermelstein, Douglas A. Hamilton, et al.. (2008). The Analgesic Efficacy and Safety of a Novel Intranasal Morphine Formulation (Morphine plus Chitosan), Immediate Release Oral Morphine, Intravenous Morphine, and Placebo in a Postsurgical Dental Pain Model. Anesthesia & Analgesia. 107(6). 2018–2024. 21 indexed citations
6.
Leeson, Rachel, et al.. (2007). Dyloject, a Novel Injectable Diclofenac Formulation, Offers Greater Safety and Efficacy Than Voltarol for Postoperative Dental Pain. Regional Anesthesia & Pain Medicine. 32(4). 303–310. 32 indexed citations
7.
Hamilton, Douglas A., et al.. (2007). Analgesic Efficacy and Safety of Morphine-Chitosan Nasal Solution in Patients with Moderate to Severe Pain Following Orthopedic Surgery. Pain Medicine. 9(1). 3–12. 34 indexed citations
8.
9.
Leeson, Rachel, et al.. (2007). Dyloject, a Novel Injectable Diclofenac Formulation, Offers Greater Safety and Efficacy Than Voltarol for Postoperative Dental Pain. Regional Anesthesia & Pain Medicine. 32(4). 303–310. 20 indexed citations
10.
Carr, Daniel B., Leonidas C. Goudas, William T. Denman, et al.. (2004). Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study. Pain. 108(1). 17–27. 136 indexed citations
11.
Mermelstein, Fred, Kam C. Yeung, Jing Cao, et al.. (1996). Requirement of a corepressor for Dr1-mediated repression of transcription.. Genes & Development. 10(8). 1033–1048. 114 indexed citations
12.
Shiekhattar, Ramin, Fred Mermelstein, Robert P. Fisher, et al.. (1995). Cdk-activating kinase complex is a component of human transcription factor TFIIH. Nature. 374(6519). 283–287. 377 indexed citations
13.
Yeung, Kam C., Juan Inostroza, Fred Mermelstein, Chitra Kannabiran, & Danny Reinberg. (1994). Structure-function analysis of the TBP-binding protein Dr1 reveals a mechanism for repression of class II gene transcription.. Genes & Development. 8(17). 2097–2109. 86 indexed citations
14.
W.L., David, Hajime Watanabe, Fred Mermelstein, et al.. (1993). Isolation of a cDNA encoding the largest subunit of TFIIA reveals functions important for activated transcription.. Genes & Development. 7(11). 2246–2257. 78 indexed citations
15.
Mermelstein, Fred, et al.. (1992). Dr1, a TATA-binding protein-associated phosphoprotein and inhibitor of class II gene transcription. Cell. 70(3). 477–489. 346 indexed citations
16.
Frackelton, A. Raymond, et al.. (1991). [8] Generation of monoclonal antibodies against phosphotyrosine and their use for affinity purification of phosphotyrosine-containing proteins. Methods in enzymology on CD-ROM/Methods in enzymology. 201. 79–92. 32 indexed citations
17.
18.
Mermelstein, Fred, Osvaldo Flores, & Danny Reinberg. (1989). Initiation of transcription by RNA polymerase II. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1009(1). 1–10. 61 indexed citations
19.
Mermelstein, Fred, et al.. (1989). Inhibition of epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid cells following psoralen/ultraviolet light treatment.. Molecular Pharmacology. 36(6). 848–855. 36 indexed citations
20.
Merino, Alejandro, Leonard Buckbinder, Fred Mermelstein, & Danny Reinberg. (1989). Phosphorylation of cellular proteins regulates their binding to the cAMP response element. Journal of Biological Chemistry. 264(35). 21266–21276. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Worthington Breakdown of academic impact, for papers by Richard A. Lewis Breakdown of academic impact, for papers by Rong Zhao Breakdown of academic impact, for papers by Ken Iseki Breakdown of academic impact, for papers by J Otten Breakdown of academic impact, for papers by Christopher T. Campbell Breakdown of academic impact, for papers by Lingyan Wang Breakdown of academic impact, for papers by Hideo Fukui Breakdown of academic impact, for papers by Guoshuai Cai Breakdown of academic impact, for papers by Wei Cui
Rankless by CCL
2026